The DOI matches its Crossref record; 70 of the 71 references it cites were found in a registry or an index.
Interaction of the Fanconi Anemia Proteins and BRCA1 in a Common Pathway
Open accessAbstract
Fanconi anemia (FA) is a human autosomal recessive cancer susceptibility disorder characterized by cellular sensitivity to mitomycin C and ionizing radiation. Although six FA genes (for subtypes A, C, D2, E, F, and G) have been cloned, their relationship to DNA repair remains unknown. In the current study, we show that a nuclear complex containing the FANCA, FANCC, FANCF, and FANCG proteins is required for the activation of the FANCD2 protein to a monoubiquitinated isoform. In normal (non-FA) cells, FANCD2 is monoubiquitinated in response to DNA damage and is targeted to nuclear foci (dots). Activated FANCD2 protein colocalizes with the breast cancer susceptibility protein, BRCA1, in ionizing radiation-induced foci and in synaptonemal complexes of meiotic chromosomes. The FANCD2 protein, therefore, provides the missing link between the FA protein complex and the cellular BRCA1 repair machinery. Disruption of this pathway results in the cellular and clinical phenotype common to all FA subtypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Since BRCA1 interacts with FancD2 and mediates FancD2 foci formation after treatment with MMC (Bunting et al., 2012; Garcia-Higuera et al., 2001; Vandenberg et al., 2003)”
From The BRCA1-Interacting Protein Abraxas Is Required for Genomic Stability and Tumor Suppression (2014) · cites this paper as Garcia-Higuera et al., 2001
Experimental — accuracy not yet measuredIn the citing paper
“In addition, DNA damage induces the accumulation of BRCA-FA proteins in nuclear foci [33].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The ubiquitin-proteasome proteolytic pathway
Ciechanover, A. J. (1994) · Cell · doi:10.1016/0092-8674(94)90396-4 · Cited by 1,804
Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells
Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81847-4 · Cited by 1,459
Joazeiro, C. A. P., & Weissman, A. M. (2000) · Cell · doi:10.1016/s0092-8674(00)00077-5 · Cited by 1,249
Brca1 Controls Homology-Directed DNA Repair
Moynahan, M. E., Chiu, J. W., Koller, B. H., & Jasin, M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80202-6 · Cited by 1,245
Wang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S. J., & Qin, J. (2000) · Genes & Development · doi:10.1101/gad.14.8.927 · Cited by 1,221
RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination
Lorick, K. L., Jensen, J. P., Fang, S., Ong, A. M., Hatakeyama, S., & Weissman, A. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11364 · Cited by 1,151
Cortez, D., Wang, Y., Qin, J., & Elledge, S. J. (1999) · Science · doi:10.1126/science.286.5442.1162 · Cited by 1,020
A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase.
Huibregtse, J. M., Scheffner, M., Beaudenon, S. L., & Howley, P. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2563 · Cited by 1,011
Ubiquitin-dependent c-Jun degradation in vivo is mediated by the δ domain
Treier, M., Staszewski, L. M., & Bohmann, D. (1994) · Cell · doi:10.1016/s0092-8674(94)90502-9 · Cited by 919
Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage
Scully, R., Chen, J., Ochs, R. L., Keegan, K., Hoekstra, M., Feunteun, J., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80503-6 · Cited by 900
Cited by
Sorted by citations
Items 101–200 of 1,000
Wang, A. T., Kim, T., Wagner, J. E., Conti, B. A., Lach, F. P., Huang, A. L., Molina, H., Sanborn, E. M., Zierhut, H. A., Cornes, B. K., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.009 · Cited by 287
Double-strand breaks and tumorigenesis
Pierce, A. J., Stark, J. M., Araujo, F. D., Moynahan, M. E., Berwick, M., & Jasin, M. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02149-3 · Cited by 269
Rosen, E. M., Fan, S., Pestell, R. G., & Goldberg, I. D. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10257 · Cited by 279
Fanconi anemia gene mutations in young-onset pancreatic cancer.
van der Heijden, M. S., Yeo, C. J., Hruban, R. H., & Kern, S. E. (2003) · PubMed · Cited by 262
Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout micePreprint
Houghtaling, S. R., Timmers, C. D., Noll, M., Finegold, M. J., Jones, S. N., Meyn, M. S., & Grompe, M. (2003) · Genes & Development · doi:10.1101/gad.1103403 · Cited by 266
Self-citationThe BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity
Baer, R. J. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(01)00269-6 · Cited by 263
Gari, K., Décaillet, C., Stasiak, A. Z., Stasiak, A., & Constantinou, A. (2008) · Molecular Cell · doi:10.1016/j.molcel.2007.11.032 · Cited by 274
BRCA1 functions independently of homologous recombination in DNA interstrand crosslink repair
Bunting, S. F., Callén, E., Kozak, M. L., Kim, J. M., Wong, N., López-Contreras, A. J., Ludwig, T., Baer, R., Faryabi, R. B., Malhowski, A., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.02.015 · Cited by 252
Self-citationA subset of ATM‐ and ATR‐dependent phosphorylation events requires the BRCA1 protein
Foray, N., Marot, D., Gabriel, A., Randrianarison-Huetz, V., Carr, A. M., Perricaudet, M., Ashworth, A., & Jeggo, P. A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg274 · Cited by 266
Inactivation of Murine Usp1 Results in Genomic Instability and a Fanconi Anemia Phenotype
Kim, J. M., Parmar, K., Huang, M., Weinstock, D. M., Ruit, C. A., Kutok, J. L., & D’Andrea, A. D. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.01.001 · Cited by 246
Self-citationFANCM Connects the Genome Instability Disorders Bloom's Syndrome and Fanconi Anemia
Deans, A. J., & West, S. C. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.12.006 · Cited by 245
Cumming, R. C., Lightfoot, J., Beard, K. M., Youssoufian, H., O'Brien, P. J., & Buchwald, M. (2001) · Nature Medicine · doi:10.1038/89937 · Cited by 245
Dufour, C. (2003) · Blood · doi:10.1182/blood-2003-01-0114 · Cited by 249
Ku70 Corrupts DNA Repair in the Absence of the Fanconi Anemia Pathway
Pace, P., Mosedale, G., Hodskinson, M. R. G., Rosado, I. V., Sivasubramaniam, M., & Patel, K. J. (2010) · Science · doi:10.1126/science.1192277 · Cited by 248
Distinct Functional Surface Regions on Ubiquitin
Sloper-Mould, K. E., Jemc, J. C., Pickart, C. M., & Hicke, L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103248200 · Cited by 247
Solution Structure of a CUE-Ubiquitin Complex Reveals a Conserved Mode of Ubiquitin Binding
Kang, R. S., Daniels, C. M., Francis, S. A., Shih, S. C., Salerno, W. J., Hicke, L., & Radhakrishnan, I. (2003) · Cell · doi:10.1016/s0092-8674(03)00362-3 · Cited by 241
Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes
Levitus, M., Rooimans, M. A., Steltenpool, J., Cool, N. F. C., Oostra, A. B., Mathew, C. G., Hoatlin, M. E., Waisfisz, Q., Arwert, F., de Winter, J. P., et al. (2003) · Blood · doi:10.1182/blood-2003-08-2915 · Cited by 239
Lossaint, G., Larroque, M., Ribeyre, C., Bec, N., Larroque, C., Décaillet, C., Gari, K., & Constantinou, A. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.07.023 · Cited by 258
Remodeling of DNA replication structures by the branch point translocase FANCM
Gari, K., Décaillet, C., Delannoy, M., Wu, L., & Constantinou, A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804777105 · Cited by 234
The Fanconi Anemia DNA Repair Pathway: Structural and Functional Insights into a Complex Disorder
Walden, H., & Deans, A. J. (2014) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-051013-022737 · Cited by 241
Cellular Responses to DNA Damage: One Signal, Multiple Choices
Su, T. T. (2006) · Annual Review of Genetics · doi:10.1146/annurev.genet.40.110405.090428 · Cited by 235
Chromosome instability syndromes
Taylor, A. M. R., Rothblum‐Oviatt, C., Ellis, N. A., Hickson, I. D., Meyer, S., Crawford, T. O., Smogorzewska, A., Pietrucha, B. M., Weemaes, C. M. R., & Stewart, G. S. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0113-0 · Cited by 242
The ubiquitous role of ubiquitin in the DNA damage response
Al-Hakim, A., Escribano‐Diaz, C., Landry, M.-C., O’Donnell, L., Panier, S., Szilard, R. K., & Durocher, D. (2010) · DNA repair · doi:10.1016/j.dnarep.2010.09.011 · Cited by 240
The DNA crosslink‐induced S‐phase checkpoint depends on ATR–CHK1 and ATR–NBS1–FANCD2 pathways
Pichierri, P., & Rosselli, F. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600113 · Cited by 228
Rothfuß, A., & Grompe, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.24.1.123-134.2004 · Cited by 222
Self-citationShao, G., Lilli, D. R., Patterson-Fortin, J., Coleman, K. A., Morrissey, D. E., & Greenberg, R. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807485106 · Cited by 221
Array Comparative Genomic Hybridization Analysis of Genomic Alterations in Breast Cancer Subtypes
Loo, L. W. M., Grove, D. I., Williams, E. M., Neal, C. L., Cousens, L. A., Schubert, E. L., Holcomb, I. N., Massa, H. F., Glogovac, J. K., Li, C. I., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1992 · Cited by 218
Autoubiquitination of the BRCA1·BARD1 RING Ubiquitin Ligase
Chen, A., Kleiman, F. E., Manley, J. L., Ouchi, T., & Pan, Z. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201252200 · Cited by 223
Bornstein, S., White, R. A., Malkoski, S. P., Oka, M., Han, G., Cleaver, T. G., Reh, D. D., Andersen, P. E., Gross, N. D., Olson, S. B., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38854 · Cited by 216
Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way
Santarosa, M., & Ashworth, A. (2004) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2004.01.001 · Cited by 220
Proteasome Function Is Required for DNA Damage Response and Fanconi Anemia Pathway Activation
Jacquemont, C. F., & Taniguchi, T. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1015 · Cited by 213
Self-citationCollis, S. J., Ciccia, A., Deans, A. J., Hořejšı́, Z., Martin, J. S., Maslen, S., Skehel, M. J., Elledge, S. J., West, S. C., & Boulton, S. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.10.014 · Cited by 220
Bridge, W. L., Vandenberg, C. J., Franklin, R., & Hiom, K. J. (2005) · Nature Genetics · doi:10.1038/ng1627 · Cited by 209
Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways
Hussain, S. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh135 · Cited by 212
The Role of the BRCA1 Tumor Suppressor in DNA Double-Strand Break Repair
Zhang, J., & Powell, S. N. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0192 · Cited by 213
The genetic and molecular basis of Fanconi anemia
de Winter, J. P., & Joenje, H. (2008) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.11.004 · Cited by 213
Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway
Chirnomas, D., Taniguchi, T., de la Vega, M., Vaidya, A. P., Vasserman, M., Hartman, A., Kennedy, R. D., Foster, R., Mahoney, J., Seiden, M. V., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0493 · Cited by 204
Self-citationInterplay between Fanconi anemia and homologous recombination pathways in genome integrity
Michl, J., Zimmer, J., & Tarsounas, M. (2016) · The EMBO Journal · doi:10.15252/embj.201693860 · Cited by 217
Protein interactions and disease: computational approaches to uncover the etiology of diseases
Kann, M. G. (2007) · Briefings in Bioinformatics · doi:10.1093/bib/bbm031 · Cited by 202
HP1α recruitment to DNA damage by p150CAF-1 promotes homologous recombination repair
Baldeyron, C., Soria, G., Roche, D., Cook, A. J. L., & Almouzni, G. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201101030 · Cited by 200
Deubiquitination of FANCD2 Is Required for DNA Crosslink Repair
Oestergaard, V. H., Langevin, F., Kuiken, H. J., Pace, P., Niedźwiedź, W., Simpson, L. J., Ohzeki, M., Takata, M., Sale, J. E., & Patel, K. J. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.09.020 · Cited by 202
Linking the Cellular Functions ofBRCAGenes to Cancer Pathogenesis and Treatment
Venkitaraman, A. R. (2008) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.3.121806.151422 · Cited by 201
Kais, Z., Rondinelli, B., Holmes, A. L., O’Leary, C., Kozono, D., D’Andrea, A. D., & Ceccaldi, R. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.031 · Cited by 208
Self-citationInvolvement of SLX4 in interstrand cross-link repair is regulated by the Fanconi anemia pathway
Yamamoto, K. N., Kobayashi, S., Tsuda, M., Kurumizaka, H., Takata, M., Kono, K., Jiricny, J., Takeda, S., & Hirota, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018487108 · Cited by 197
Hirsch, B. A., Shimamura, A., Moreau, L. A., Baldinger, S. R., Hag-alshiekh, M., Bostrom, B., Sencer, S., & D’Andrea, A. D. (2003) · Blood · doi:10.1182/blood-2003-06-1970 · Cited by 199
Self-citationTracing the network connecting brca and fanconi anaemia proteins
Venkitaraman, A. R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1321 · Cited by 202
Enhancement of BRCA1 E3 Ubiquitin Ligase Activity through Direct Interaction with the BARD1 Protein
Xia, Y., Pao, G. M., Chen, H.-W., Verma, I. M., & Hunter, T. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m204591200 · Cited by 199
Quantitative Analysis of global Ubiquitination in HeLa Cells by Mass Spectrometry
Meierhofer, D., Wang, X., Huang, L., & Kaiser, P. (2008) · Journal of Proteome Research · doi:10.1021/pr800468j · Cited by 197
Mechanistic Insight into Site-Restricted Monoubiquitination of FANCD2 by Ube2t, FANCL, and FANCI
Alpi, A. F., Pace, P., Babu, M. M., & Patel, K. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.12.003 · Cited by 192
Schärer, O. D. (2005) · ChemBioChem · doi:10.1002/cbic.200400287 · Cited by 195
The vertebrate Hef ortholog is a component of the Fanconi anemia tumor-suppressor pathway
Mosedale, G., Niedźwiedź, W., Alpi, A. F., Perrina, F., Pereira‐Leal, J. B., Johnson, M. A., Langevin, F., Pace, P., & Patel, K. J. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb981 · Cited by 191
Cell cycle–dependent chromatin loading of the Fanconi anemia core complex by FANCM/FAAP24
Kim, J. M., Kee, Y., Gurtan, A. M., & D’Andrea, A. D. (2008) · Blood · doi:10.1182/blood-2007-09-113092 · Cited by 199
Self-citationMechanism and regulation of incisions during DNA interstrand cross-link repair
Zhang, J., & Walter, J. C. (2014) · DNA repair · doi:10.1016/j.dnarep.2014.03.018 · Cited by 194
DNA damage response – A double-edged sword in cancer prevention and cancer therapy
Tian, H., Gao, Z., Li, H., Zhang, B., Wang, G., Zhang, Q., Pei, D., & Zheng, J. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.12.038 · Cited by 189
Fanconi anemia: a model disease for studies on human genetics and advanced therapeutics
Bogliolo, M., & Surrallés, J. (2015) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2015.07.002 · Cited by 194
Enoiu, M., Jiricny, J., & Schärer, O. D. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks670 · Cited by 192
Genetic basis of Fanconi anemia
Bagby, G. C. (2003) · Current Opinion in Hematology · doi:10.1097/00062752-200301000-00011 · Cited by 183
Cohen, P. E., Pollack, S. E., & Pollard, J. W. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0017 · Cited by 189
Grompe, M. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.20.2253 · Cited by 189
Self-citationBRCA-related ATM-mediated DNA double-strand break repair and ovarian aging
Turan, V., & Oktay, K. (2019) · Human Reproduction Update · doi:10.1093/humupd/dmz043 · Cited by 181
Wong, J. C. Y. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg219 · Cited by 181
From UBA to UBX: new words in the ubiquitin vocabulary
Buchberger, A. (2002) · Trends in Cell Biology · doi:10.1016/s0962-8924(02)02269-9 · Cited by 175
The ubiquitin system, disease, and drug discovery
Petroski, M. D. (2008) · BMC Biochemistry · doi:10.1186/1471-2091-9-s1-s7 · Cited by 184
Kennedy, R. D., Chen, C. C., Stuckert, P., Archila, E. M., la Vega, M. A. D., Moreau, L. A., Shimamura, A., & D’Andrea, A. D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31245 · Cited by 178
Self-citationFANCE: the link between Fanconi anaemia complex assembly and activity
Pace, P., Johnson, M., Tan, W. M., Mosedale, G., Sng, C. C. A., Hoatlin, M., de Winter, J. P., Joenje, H., Gergely, F. V., & Patel, K. J. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf355 · Cited by 172
A network medicine approach to human disease
Zanzoni, A., Soler‐López, M., & Aloy, P. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.03.001 · Cited by 172
Chromosome instability syndromes
Taylor, A. M. R. (2001) · Best Practice & Research Clinical Haematology · doi:10.1053/beha.2001.0158 · Cited by 170
Small-Molecule Inhibitors of USP1 Target ID1 Degradation in Leukemic Cells
Mistry, H. S., Hsieh, G., Buhrlage, S. J., Huang, M., Park, E., Cuny, G. D., Galinsky, I. A., Stone, R. M., Gray, N. S., D’Andrea, A. D., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0103-t · Cited by 169
Self-citationThe ubiquitin system: pathogenesis of human diseases and drug targeting
Ciechanover, A. J., & Schwartz, A. L. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.09.018 · Cited by 171
FAAP100 is essential for activation of the Fanconi anemia‐associated DNA damage response pathway
Ling, C., Ishiai, M., Ali, A. M., Medhurst, A. L., Neveling, K., Kalb, R., Yan, Z., Xue, Y., Oostra, A. B., Auerbach, A. D., et al. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601666 · Cited by 170
Mouse models of Fanconi anemia
Parmar, K., D’Andrea, A. D., & Niedernhofer, L. J. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2009.03.015 · Cited by 174
Self-citationDNA damage response pathway in radioadaptive response
Sasaki, M. S., Ejima, Y., Tachibana, A., Yamada, T., Ishizaki, K., Shimizu, T., & Nomura, T. (2002) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(02)00084-2 · Cited by 166
DNA Repair Defects in Stem Cell Function and Aging
Park, Y., & Gerson, S. L. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.56.082103.104546 · Cited by 172
Why does the bone marrow fail in Fanconi anemia?
Garaycoechea, J. I., & Patel, K. J. (2013) · Blood · doi:10.1182/blood-2013-09-427740 · Cited by 173
A chemical-genetic screen reveals a mechanism of resistance to PI3K inhibitors in cancer
Muellner, M. K., Uras, I. Z., Gapp, B. V., Kerzendorfer, C., Šmída, M., Lechtermann, H., Craig-Mueller, N., Colinge, J., Duernberger, G., & Nijman, S. M. B. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.695 · Cited by 165
BRCA Mutations, DNA Repair Deficiency, and Ovarian Aging1
Oktay, K., Turan, V., Titus, S., Stobezki, R., & Liu, L. (2015) · Biology of Reproduction · doi:10.1095/biolreprod.115.132290 · Cited by 165
FANCD2 Facilitates Replication through Common Fragile Sites
Madireddy, A., Kosiyatrakul, S. T., Boisvert, R. A., Herrera‐Moyano, E., García-Rubio, M. L., Gerhardt, J., Vuono, E. A., Owen, N. M., Yan, Z., Olson, S. B., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.09.017 · Cited by 174
Fanconi anaemia and leukaemia – clinical and molecular aspects
Tischkowitz, M. D., & Dokal, I. S. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05023.x · Cited by 166
Targeting the DNA repair defect of BRCA tumours
Turner, N. C., Tutt, A. N. J., & Ashworth, A. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.03.006 · Cited by 164
Eladad, S., Ye, T.-Z., Hu, P., Leversha, M. A., Beresten, S. F., Matunis, M. J., & Ellis, N. A. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi145 · Cited by 158
Chen, Y.-H., Jones, M. V., Yin, Y., Crist, S. B., Colnaghi, L., Sims, R. J., Rothenberg, E., Jallepalli, P. V., & Huang, T. T. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.02.031 · Cited by 167
Schoenfeld, A. R., Apgar, S., Dolios, G., Wang, R., & Aaronson, S. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.17.7444-7455.2004 · Cited by 161
Menin associates with FANCD2, a protein involved in repair of DNA damage.
Jin, S., Mao, H., Schnepp, R. W., Sykes, S. M., Silva, A. C., D’Andrea, A. D., & Hua, X. (2003) · PubMed · Cited by 157
Self-citationMamrak, N. E., Shimamura, A., & Howlett, N. G. (2016) · Blood Reviews · doi:10.1016/j.blre.2016.10.002 · Cited by 156
Thompson, L. H., & Hinz, J. M. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2009.02.003 · Cited by 155
Nishimura, K., Ishiai, M., Horikawa, K., Fukagawa, T., Takata, M., Takisawa, H., & Kanemaki, M. T. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.05.047 · Cited by 152
Lin, W. T., Beattie, M. S., Chen, L.-M., Oktay, K., Crawford, S. L., Gold, E. B., Cedars, M. I., & Rosen, M. P. (2013) · Cancer · doi:10.1002/cncr.27952 · Cited by 151
Genetic Heterogeneity among Fanconi Anemia Heterozygotes and Risk of Cancer
Berwick, M., Satagopan, J. M., Ben‐Porat, L., Carlson, A. D., Mah, K., Henry, R., Diotti, R., Milton, K., Pujara, K., Landers, T., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1501 · Cited by 155
BRCA1 Facilitates Microhomology-mediated End Joining of DNA Double Strand Breaks
Zhong, Q., Chen, C., Chen, P., & Lee, W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200748200 · Cited by 155
Yamamoto, K., Ishiai, M., Matsushita, N., Arakawa, H., Lamerdin, J. E., Buerstedde, J.-M., Tanimoto, M., Harada, M., Thompson, L. H., & Takata, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.15.5421-5430.2003 · Cited by 151
Structure of the FANCI-FANCD2 Complex: Insights into the Fanconi Anemia DNA Repair Pathway
Joo, W. S., Xu, G., Persky, N. S., Smogorzewska, A., Rudge, D. G., Buzovetsky, O., Elledge, S. J., & Pavletich, N. P. (2011) · Science · doi:10.1126/science.1205805 · Cited by 149
Soulier, J., Leblanc, T. M., Larghero, J., Dastot, H., Shimamura, A., Guardiola, P., Espérou, H., Ferry, C., Jubert, C., Feugeas, J., et al. (2004) · Blood · doi:10.1182/blood-2004-05-1852 · Cited by 153
Self-citationChk1-Mediated Phosphorylation of FANCE Is Required for the Fanconi Anemia/BRCA Pathway
Wang, X., Kennedy, R. D., Ray, K., Stuckert, P., Ellenberger, T., & D’Andrea, A. D. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02357-06 · Cited by 147
Self-citationMultiple Roles for Rsp5p-dependent Ubiquitination at the Internalization Step of Endocytosis
Dunn, R., & Hicke, L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104113200 · Cited by 147
Mechanisms of Vertebrate DNA Interstrand Cross-Link Repair
Semlow, D. R., & Walter, J. C. (2021) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-080320-112510 · Cited by 148
Ubiquitin-binding domains and their role in the DNA damage response
Hofmann, K. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.01.003 · Cited by 142
Validating the concept of mutational signatures with isogenic cell models
Zou, X., Owusu, M., Harris, R., Jackson, S. P., Loizou, J. I., & Nik‐Zainal, S. (2018) · Nature Communications · doi:10.1038/s41467-018-04052-8 · Cited by 144
Rickman, K. A., Lach, F. P., Abhyankar, A., Donovan, F. X., Sanborn, E. M., Kennedy, J. A., Sougnez, C. L., Gabriel, S., Elemento, O., Chandrasekharappa, S. C., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.06.014 · Cited by 141
Chromosome breakage syndromes and cancer
Duker, N. J. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10688 · Cited by 146
Deconstructing the molecular portrait of basal-like breast cancer
Yehiely, F., Moyano, J. V., Evans, J. R., Nielsen, T. O., & Cryns, V. L. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.09.004 · Cited by 144
Metadata
- Authors
- Garcia-Higuera, I., Taniguchi, T., Ganesan, S., Meyn, M. S., Timmers, C., Hejna, J., Grompe, M., & D'Andrea, A. D.
- Affiliations
- Harvard University (US)
- Dana-Farber Cancer Institute (US)
- Hospital for Sick Children (CA)
- Oregon Health & Science University (US)
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2001-02
- Volume
- 7
- Issue
- 2
- Pages
- 249-262
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W1991841649
- Cited by
- 1,198
- References
- 71
- Citations by year
- 2026: 14 · 2025: 13 · 2024: 14 · 2023: 20 · 2022: 15 · 2021: 24 · 2020: 25 · 2019: 41 · 2018: 28 · 2017: 20 · 2016: 54 · 2015: 49 · 2014: 51 · 2013: 44 · 2012: 66
- FWCI
- 31.72
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Molecular Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL54785-04, R01HL52725-04, R01HL052725)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK043889, R01DK43889-09)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Keywords
- Fanconi anemia, BRCA1, FANCD2 monoubiquitination, FANCA, FANCC, FANCF, FANCG, DNA repair, radiosensitivity, mitomycin C sensitivity, synaptonemal complex, meiotic chromosomes, nuclear foci, cancer susceptibility
- MeSH terms
- Animals, Cell Line, Cell Survival, DNA Damage, DNA-Binding Proteins, Fanconi Anemia, Fluorescent Antibody Technique, Genetic Complementation Test, Humans, Male, Meiosis, Nuclear Proteins, Protein Binding, Proteins, Radiation, Ionizing, Spermatocytes, Synaptonemal Complex, Ubiquitins, Ultraviolet Rays, Mitomycin, Cell Cycle Proteins, BRCA1 Protein, Active Transport, Cell Nucleus, Macromolecular Substances, Mice, Fanconi Anemia Complementation Group Proteins, Fanconi Anemia Complementation Group C Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review